Valion Bio (VBIO) Asset Writedowns and Impairment (2021 - 2024)
Valion Bio (VBIO) posted quarterly Asset Writedowns and Impairment of $338000.0 for Q4 2024, up 6860.0% quarter-over-quarter from -$5000.0 in Q2 2022.
Valion Bio (VBIO) Asset Writedowns and Impairment (2021 - 2024) Analysis & Trends
Valion Bio's Asset Writedowns and Impairment history runs 3 years deep, the most recent figure standing at $338000.0 for Q4 2024.
- In Q4 2024, Asset Writedowns and Impairment changed N/A year-over-year to $338000.0; the TTM figure through Dec 2024 stood at $338000.0 (changed N/A YoY), while the FY2024 annual figure was $354000.0, up 1006.25% from the prior year.
- Asset Writedowns and Impairment for Q4 2024 stood at $338000.0, up from -$5000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $338000.0 in Q4 2024, with the low at -$30000.0 in Q2 2021.
- The 3-year median for Asset Writedowns and Impairment is $1000.0 (2021), against an average of $47142.9.
- Peak annual rise in Asset Writedowns and Impairment reached 83.33% in 2022, while the deepest fall reached 77.27% in 2022.
- Valion Bio's Asset Writedowns and Impairment stood at $1000.0 in 2021, then plunged by 600.0% to -$5000.0 in 2022, then surged by 6860.0% to $338000.0 in 2024.
- Business Quant data shows VBIO's Asset Writedowns and Impairment at $338000.0 in Q4 2024, -$5000.0 in Q2 2022, and $5000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Valion Bio | 405,599.63 | -1.79 Mn | -45,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 338,000.00 |
| Dec 31, 2024 | 338,000.00 |
| Jun 30, 2022 | -5,000.00 |
| Jun 30, 2022 | -5,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | -1,000.00 |
| Sep 30, 2021 | -1,000.00 |
| Jun 30, 2021 | -30,000.00 |
| Jun 30, 2021 | -30,000.00 |
| Mar 31, 2021 | 22,000.00 |
| Mar 31, 2021 | 22,000.00 |